Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Aripiprazole tablet
DRUG
3 trials
Sponsors
Otsuka Beijing Research Institute
, All India Institute of Medical Sciences, Bhubaneswar
, Vigonvita Life Sciences
Conditions
Clozapine Resistant Schizophrenia
Schizophrenia
Phase 2
Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
Not yet recruiting
NCT07703956
Vigonvita Life Sciences
Schizophrenia
Start: 2026-07-31
End: 2027-12-31
Target: 500
Updated: 2026-07-15
Phase 3
Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia
Completed
NCT03172871
Otsuka Beijing Research Institute
Schizophrenia
Start: 2017-05-15
End: 2019-09-30
Updated: 2020-12-29
Phase 4
Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia
Not yet recruiting
NCT06501339
All India Institute of Medical Sciences, Bhubaneswar
Clozapine Resistant Schizophrenia
Start: 2024-08-10
End: 2026-03-31
Target: 40
Updated: 2024-07-16
Related Papers
Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study.
2022-01-06
10 citations